Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cancer survivors may be at higher risk for cognitive dysfunction

01.06.2005


More research needed to clarify cause and extent of impairment, say USC psychologists



Cancer survivors are twice as likely to develop cognitive problems as individuals who have never been treated for cancer, according to an article in the June 1 Journal of the National Cancer Institute. Previous research has raised concerns about a possible link among cancer, cancer therapies and cognitive dysfunction. This study found that long-term cancer survivors were at increased risk of cognitive impairment. An accompanying editorial urged a cautious interpretation of the results pending further research.

In the study, USC psychologists studied 702 cancer survivors and their cancer-free twins in the Swedish Twin Registry. Studying twins removes statistical influences from genetic or early childhood causes of both cancer and cognitive deficits. Working with colleagues at the Karolinska Institute and Gothenberg University in Sweden, the researchers evaluated the survivors through a standardized mental status interview.


Participants were scored on a scale from zero to three. Anyone who scored a three, defined as having verbal, orientation or recall problems that interfere with daily life, was considered to have cognitive dysfunction. "The twin who had cancer was more likely to have some sort of cognitive dysfunction," said Beth Meyerowitz, professor of psychology in the USC College of Letters, Arts and Sciences. About 15 percent of the cancer survivors in the study showed cognitive dysfunction.

Previous studies have found cognitive problems in short-term cancer survivors, said coauthor Lara Heflin, a doctoral student in psychology at USC. This study is the first to find significant cognitive differences between long-term survivors and cancer-free individuals, she said, and to focus on older adult survivors. "This suggests that possibly the cognitive dysfunction gets worse over time with increased survival duration," Heflin said.

The comparison with cancer-free twins means that the increased dysfunction cannot be attributed to the normal aging process. The researchers also found a doubled risk of dementia in the survivor group. However, the result was not statistically significant.

Heflin plans to study patient data from Los Angeles County’s Cancer Surveillance Project and USC’s Alzheimer Disease Research Center to investigate the possible link between dementia and cancer.

The study does not suggest a cause for the cognitive problems in cancer survivors. The researchers excluded survivors of tumors that directly affect the central nervous system.

One possibility is that chemotherapy or other cancer treatments may cause long-term damage. The researchers plan a follow-up study comparing survivors who received different treatments. "If, five, eight, 10 years down the line, having had that treatment is going to increase a person’s risk of dementia, that’s something that should be considered by the physician and the patient," Meyerowitz said. "Maybe a lower dose might be useful for the cancer but would reduce risk of cognitive dysfunction."

"Those with cancer might also be advised to have their cognition monitored as part of long-term follow-up," added Margaret Gatz, professor of psychology at USC and foreign adjunct professor of medical epidemiology and biostatistics at the Karolinska Institute.

Carl Marziali | EurekAlert!
Further information:
http://www.usc.edu

More articles from Studies and Analyses:

nachricht The importance of biodiversity in forests could increase due to climate change
17.11.2017 | Deutsches Zentrum für integrative Biodiversitätsforschung (iDiv) Halle-Jena-Leipzig

nachricht Win-win strategies for climate and food security
02.10.2017 | International Institute for Applied Systems Analysis (IIASA)

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Previous evidence of water on mars now identified as grainflows

21.11.2017 | Physics and Astronomy

NASA's James Webb Space Telescope completes final cryogenic testing

21.11.2017 | Physics and Astronomy

New catalyst controls activation of a carbon-hydrogen bond

21.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>